Home/Pinion Immunotherapeutics/Regina Jakacki, MD

RJ

Regina Jakacki, MD

CMO

Pinion Immunotherapeutics

Therapeutic Areas

Oncology Infectious Disease

Pinion Immunotherapeutics Pipeline

Drug	Indication	Phase
ARV-2001	HPV-16 Precancer	Preclinical
DCAR-001	AML Immunotherapy	Preclinical
ARV-1004	EBV Therapeutic	Preclinical
ARV-1003	HBV Therapeutic	Preclinical
Undisclosed	HSV Therapeutic	Preclinical

Leadership Team at Pinion Immunotherapeutics

Gregory Glenn, MD

Renhuan Xu, PhD

CSO, Co-founder

Jianzhu Chen, PhD

Co-founder, Scientific Advisor

View full Pinion Immunotherapeutics profile